PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20013881-0	2010	Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation.	3,4-dihydroxyphenylethanol	15-29	mitogen-activated protein kinase 3	Homo sapiens	94-100	
23995352-9	2014	Pretreatment with a PKA inhibitor (Rp-cAMPs) and an ERK1/2 inhibitor (U0126) significantly attenuated hydroxytyrosol-stimulated lipolysis.	3,4-dihydroxyphenylethanol	102-116	mitogen-activated protein kinase 3	Homo sapiens	52-58	
19685549-0	2009	Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1.	3,4-dihydroxyphenylethanol	0-14	mitogen-activated protein kinase 3	Homo sapiens	100-106	
28711992-0	2017	Oleuropein and hydroxytyrosol inhibit the N-formyl-methionyl-leucyl-phenylalanine-induced neutrophil degranulation and chemotaxis via AKT, p38, and ERK1/2 MAP-Kinase inhibition.	3,4-dihydroxyphenylethanol	15-29	mitogen-activated protein kinase 3	Homo sapiens	148-154	
23995352-13	2014	CONCLUSION: Hydroxytyrosol induced lipolysis in 3T3-L1 adipocytes via the activation of PKA and ERK1/2 pathway.	3,4-dihydroxyphenylethanol	12-26	mitogen-activated protein kinase 3	Homo sapiens	96-102	
24019118-1	2014	SCOPE: We have previously demonstrated that oleuropein (OL) and hydroxytyrosol (HT) reduce 17beta-estradiol-mediated proliferation in MCF-7 breast cancer (BC) cells without affecting the classical genomic action of estrogen receptor (ER), but activating instead the ERK1/2 pathway.	3,4-dihydroxyphenylethanol	64-78	mitogen-activated protein kinase 3	Homo sapiens	266-272